.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Citi
Boehringer Ingelheim
Argus Health
Cerilliant
AstraZeneca
Chinese Patent Office
QuintilesIMS
US Department of Justice
Deloitte

Generated: September 21, 2017

DrugPatentWatch Database Preview

V-CILLIN Drug Profile

« Back to Dashboard

Which patents cover V-cillin, and when can generic versions of V-cillin launch?

V-cillin is a drug marketed by Lilly and is included in three NDAs.

The generic ingredient in V-CILLIN is penicillin v potassium. There are eighty-seven drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the penicillin v potassium profile page.

Summary for Tradename: V-CILLIN

Patents:0
Applicants:1
NDAs:3
Bulk Api Vendors: see list18
Patent Applications: see list931
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:V-CILLIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
V-CILLIN
penicillin v
FOR SUSPENSION;ORAL060002-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
V-CILLIN K
penicillin v potassium
TABLET;ORAL060003-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
V-CILLIN K
penicillin v potassium
TABLET;ORAL060003-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
V-CILLIN K
penicillin v potassium
TABLET;ORAL060003-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
V-CILLIN K
penicillin v potassium
FOR SOLUTION;ORAL060004-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
V-CILLIN K
penicillin v potassium
FOR SOLUTION;ORAL060004-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Moodys
Teva
Baxter
Citi
UBS
Harvard Business School
Healthtrust
Queensland Health
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot